FUT4 and non-small cell lung carcinoma: Although less convincing statistically, another study of 46 patients with unresectable NSCLC, treated with platinum-based chemotherapy, reported that disease progression was associated with significantly higher levels of MDSC subpopulations (CD15+ and CD14+) compared to patients with disease control (100).